Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: Role of nuclear factor-kappa B and p38 MAPK

Neonatology

Volumn 99, Issue 2, 2011, Pages 140-145

  Koch, Lutz ^a   Fritzsching, Benedikt ^a   Frommhold, David ^a   Poeschl, Johannes ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cord blood; Lipopolysaccharide; Nuclear factor kappa B; p38 mitogen activated protein kinase; Sepsis

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; SC 514; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; IMMUNE SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TH1 CELL; TH2 CELL; UMBILICAL CORD BLOOD;

ADULT; CYTOKINES; ENZYME INHIBITORS; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; IMIDAZOLES; INFANT, NEWBORN; LIPOPOLYSACCHARIDES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS; THIOPHENES;

EID: 77956067413     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000313967     Document Type: Article

References (31)

1. Lukacs SL, Schoendorf KC, Schuchat A: Trends in sepsis-related neonatal mortality in the United States, 1985-1998. Pediatr Infect Dis J 2004; 23: 599-603. (Pubitemid 38924881)
2. Zuckerman SH, Evans GF, Guthrie L: Transcriptional and post-transcriptional mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA. Immunology 1991; 73: 460-465.
3. Klein J, Remington J: Current Concepts of Infections of the Fetus and Newborn Infant. Philadelphia, Saunders, 2001.
4. Adkins B, Leclerc C, Marshall-Clarke S: Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4: 553-564. (Pubitemid 38931770)
5. Peters AM, Bertram P, Gahr M, Speer CP: Reduced secretion of interleukin-1 and tumor necrosis factor-alpha by neonatal monocytes. Biol Neonate 1993; 63: 157-162. (Pubitemid 23151542)
6. De Wit D, Tonon S, Olislagers V, Goriely S, Boutriaux M, Goldman M, Willems F: Impaired responses to Toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 2003; 21: 277-281. (Pubitemid 37410116)
7. Levy O: Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J Endotoxin Res 2005; 11: 113-116. (Pubitemid 40711487)
8. Caron JE, La Pine TR, Augustine NH, Martins TB, Hill HR: Multiplex analysis of Tolllike receptor-stimulated neonatal cytokine response. Neonatology 2010; 97: 266-273.
9. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311-320. (Pubitemid 28067327)
10. Jones SA: Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005; 175: 3463-3468. (Pubitemid 41292002)
11. Marchini G, Berggren V, Djilali-Merzoug R, Hansson LO: The birth process initiates an acute phase reaction in the fetus-newborn infant. Acta Paediatr 2000; 89: 1082-1086.
12. Schultz C, Rott C, Temming P, Schlenke P, Moller JC, Bucsky P: Enhanced interleukin- 6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002; 51: 317-322. (Pubitemid 34174967)
13. Chen F, Castranova V, Shi X, Demers LM: New insights into the role of nuclear factorkappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999; 45: 7-17. (Pubitemid 29036378)
14. Liu SF, Malik AB: NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 2006; 290:L622-L645. (Pubitemid 43738989)
15. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683. (Pubitemid 26130197)
16. Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, Hauser S, Huynh K, Bonar S, Mielke C, Albee L, Weier R, Graneto M, Hanau C, Perry T, Tripp CS: A selective IKK- 2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J Biol Chem 2003; 278: 32861-32871. (Pubitemid 37055728)
17. Phulwani NK, Esen N, Syed MM, Kielian T: TLR2 expression in astrocytes is induced by TNF-alpha- and NF-kappa B-dependent pathways. J Immunol 2008; 181: 3841-3849.
18. Killeen ME, Englert JA, Stolz DB, Song M, Han Y, Delude RL, Kellum JA, Fink MP: The phase 2 enzyme inducers ethacrynic acid, DL -sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells. J Pharmacol Exp Ther 2006; 316: 1070-1079. (Pubitemid 43345280)
19. Yan Liu X, Robinson D, Veach RA, Liu D, Timmons S, Collins RD, Hawiger J: Peptidedirected suppression of a pro-inflammatory cytokine response. J Biol Chem 2000; 275: 16774-16778. (Pubitemid 30398910)
20. Shanley TP, Warner RL, Ward PA: The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1995; 1: 40-45.
21. Kraatz J, Clair L, Rodriguez JL, West MA: Macrophage TNF secretion in endotoxin tolerance: role of SAPK, p38, and MAPK. J Surg Res 1999; 83: 158-164. (Pubitemid 29391623)
22. Shames BD, Selzman CH, Pulido EJ, Meng X, Meldrum DR, McIntyre RC Jr, Harken AH, Banerjee A: LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent. J Surg Res 1999; 83: 69-74. (Pubitemid 29394109)
23. Obata T, Brown GE, Yaffe MB: MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med 2000; 28:N67-N77. (Pubitemid 30262049)
24. Song GY, Chung CS, Chaudry IH, Ayala A: MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis. Am J Physiol Cell Physiol 2001; 281:C662-C669.
25. Branger J, van den Blink B, Weijer S, Madwed J, Bos CL, Gupta A, Yong CL, Polmar SH, Olszyna DP, Hack CE, van Deventer SJ, Peppelenbosch MP, van der Poll T: Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J Immunol 2002; 168: 4070-4077. (Pubitemid 34298414)
26. Koch L, Linderkamp O, Ittrich C, Benner A, Poeschl J: Gene expression profiles of adult peripheral and cord blood mononuclear cells altered by lipopolysaccharide. Neonatology 2008; 93: 87-100. (Pubitemid 351225337)
27. Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, Levy O: Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr Res 2006; 60: 205-209. (Pubitemid 44297594)
28. Makhseed M, Raghupathy R, Azizieh F, Omu A, Al-Shamali E, Ashkanani L: Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001; 16: 2219-2226. (Pubitemid 32951921)
29. Raghupathy R, Makhseed M, El-Shazly S, Azizieh F, Farhat R, Ashkanani L: Cytokine patterns in maternal blood after premature rupture of membranes. Obstet Gynecol 2001; 98: 122-126. (Pubitemid 32622776)
30. O'Sullivan AW, Wang JH, Redmond HP: NF-kappaB and P38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. J Surg Res 2009; 152: 46-53.
31. Bracci R, Buonocore G: Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate 2003; 83: 85-96. (Pubitemid 36184381)